Colgate-Palmolive Company $CL Shares Bought by Callan Family Office LLC

Key Points

• Callan Family Office LLC significantly increased its stake in Colgate-Palmolive Company by 286.3%, now holding 18,685 shares valued at approximately $1.7 million.
• Colgate-Palmolive's stock ratings show a consensus of "Moderate Buy" with an average price target of $92.21, as multiple analysts adjusted their price targets recently.
• The company reported a quarterly EPS of $0.92, exceeding analyst expectations, alongside a 2.7% dividend yield to be paid on November 14th.

Callan Family Office LLC raised its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 286.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 18,685 shares of the company's stock after purchasing an additional 13,848 shares during the quarter. Callan Family Office LLC's holdings in Colgate-Palmolive were worth $1,698,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Westend Capital Management LLC boosted its holdings in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 140 shares in the last quarter. Cornerstone Planning Group LLC increased its position in Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after purchasing an additional 287 shares during the last quarter. Saudi Central Bank acquired a new position in Colgate-Palmolive during the first quarter worth approximately $29,000. Ransom Advisory Ltd purchased a new stake in Colgate-Palmolive during the first quarter worth approximately $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Colgate-Palmolive during the first quarter worth approximately $37,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on CL shares. Deutsche Bank Aktiengesellschaft set a $86.00 target price on shares of Colgate-Palmolive in a research note on Friday. UBS Group decreased their price target on shares of Colgate-Palmolive from $99.00 to $92.00 and set a "buy" rating for the company in a report on Wednesday. Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating on the stock in a report on Thursday, September 25th. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $95.00 to $88.00 and set an "overweight" rating on the stock in a report on Friday. Finally, Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, Colgate-Palmolive presently has an average rating of "Moderate Buy" and a consensus price target of $92.21.

Colgate-Palmolive Stock Performance

Shares of CL opened at $77.99 on Friday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The stock has a market cap of $63.03 billion, a price-to-earnings ratio of 21.91, a PEG ratio of 4.29 and a beta of 0.34. The company has a 50-day moving average of $82.56 and a two-hundred day moving average of $87.88. Colgate-Palmolive Company has a one year low of $77.09 and a one year high of $102.61.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company posted $0.91 earnings per share. On average, equities research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.43%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.